75
Participants
Start Date
October 18, 2017
Primary Completion Date
October 13, 2020
Study Completion Date
February 25, 2021
binimetinib
Orally, twice daily.
nivolumab
Intravenously (IV) every 4 weeks (Q4W)
ipilimumab
intravenously (IV) every 8 weeks (Q8W)
UZ Leuven - Dermatology, Leuven
UZ Leuven - Ophthalmology, Leuven
UZ Leuven, Leuven
Hospital of the University of Pennsylvania, Philadelphia
Investigational Drug Service of the University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Christiana Care Health Services, Helen F. Graham Cancer Center Pharmacy, Suite 3200, Newark
Christiana Care Health Services, Helen F. Graham Cancer Center, Newark
Christiana Care Oncology Hematology, Helen F Graham Cancer Center, Suite 2400, Newark
Medical Oncology Hematology Consultants, PA, Helen F. Graham Cancer Center, Newark
Christiana Care Health Services, Christiana Hospital, Newark
Georgetown University Medical Center Department of Pharmacy, Research, Washington D.C.
Georgetown University Medical Center, Washington D.C.
Hospital General Universitario Gregorio Marañon, Madrid
Clinica Rementeria, Madrid
Hospital Universitario 12 Octubre, Madrid
Hospital HM Universitario Sanchinarro, CIOCC, Madrid
Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Tennessee Oncology NASH - SCRI - PPDS, Nashville
The Sarah Cannon Research Institute., Nashville
Tennessee Oncology, PLLC, Cleveland
Sarah Cannon Research Institute, Chattanooga
SCRI Tennessee Oncology Chattanooga, Chattanooga
Indiana CTSI Clinical Research Center (ICRC), Indianapolis
Indiana University Health Hospital, Indianapolis
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Investigational Drug Services IUHSCC, Indianapolis
Sidney &Lois Eskenazi Hospital, Indianapolis
Spring Mill Medical Center, Indianapolis
Siteman Cancer Center - North County, Florissant
Center for Outpatient Health (Dermatology Clinic), St Louis
Center for Outpatient Health (Ophthalmology Clinic), St Louis
Barnes-Jewish Hospital, St Louis
Washington University School of Medicine, St Louis
Siteman Cancer Center - South County, St Louis
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - Barnes St. Peters, City of Saint Peters
The University of Texas MD Anderson Cancer Center, Houston
UCLA Hematology/Oncology, Los Angeles
UCLA Hematology/Oncology - Santa Monica, Santa Monica
The Netherlands Cancer Institute Antoni Van Leeuwenhoek, Amsterdam
OLVG locatie Oost, Amsterdam
Amsterdam Medical Center (AMC), Amsterdam
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario Vall d'Hebrón - PPDS, Barcelona
Royal Marsden Hospital - London, London
Royal Marsden Hospital NHS Foundation Trust, London
Churchill Hospital, Oxford
Royal Marsden Hospital NHS Foundation Trust, Surrey
Royal Marsden Hospital -Fulham Road, London
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Pfizer
INDUSTRY